Pregnant and breastfeeding women: A priority population for HIV viral load monitoring

1. UNAIDS. Global AIDS Update, 2016. Geneva: UNAIDS; 2016.

2. World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach–Second edition. Geneva: WHO; 2016.

3. UNICEF. Children & AIDS 2015: Statistical Update. New York: UNICEF; 2016.

4. World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: WHO; 2013.

5. World Health Organisation. Guidelines Update on HIV and Infant Feeding. Geneva: WHO; 2016.

6. Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa. Sustainable HIV treatment in Africa through viral-load-informed differentiated care. Nature. 2015; 528(7580):S68–76. doi: 10.1038/nature16046 26633768

7. Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014; 384(9939):258–71. doi: 10.1016/S0140-6736(14)60164-1 24907868

8. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016; 375(9):830–9. doi: 10.1056/NEJMoa1600693 27424812

9. Tubiana R, Le Chenadec J, Rouzioux C, Mandelbrot L, Hamrene K, Dollfus C, et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1). Clin Infect Dis. 2010;50:585–596. doi: 10.1086/650005 20070234

10. Houle B, Clark SJ, Kahn K, Tollman S, Yamin A. The impacts of maternal mortality and cause of death on children's risk of dying in rural South Africa: evidence from a population based surveillance study (1992–2013). Reprod Health. 2015; 12 (Suppl 1):S7.

11. Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012; 26(16):2039–52. doi: 10.1097/QAD.0b013e328359590f 22951634

12. Haas AD, Msukwa MT, Egger M, Tenthani L, Tweya H, Jahn A, et al. Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program. Clin Infect Dis. 2016; 63(9):1227–1235. doi: 10.1093/cid/ciw500 27461920

13. Myer L, Dunning L, Lesosky M, Hsiao NY, Phillips T, Petro G, et al. Frequency of viremic episodes in HIV-infected women initiating antiretroviral therapy in pregnancy: A cohort study. Clin Infect Dis. 2017; 64 (4): 422–427. doi: 10.1093/cid/ciw792 27927852

14. Koss CA, Natureeba P, Kwarisiima D, Ogena M, Clark TD, Olwoch P, et al. Viral Suppression and Retention in Care up to 5 Years after Initiation of Lifelong ART during Pregnancy (Option B+) in Rural Uganda. J Acquir Immune Defic Syndr. 2017; 74(3):279–284. doi: 10.1097/QAI.0000000000001228 27828878

15. Gourlay A, Birdthistle I, Mburu G, Iorpenda K, Wringe A. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2013; 16:18588. doi: 10.7448/IAS.16.1.18588 23870277

16. Bonner K, Mezochow A, Roberts T, Ford N, Cohn J. Viral load monitoring as a tool to reinforce adherence: a systematic review. J Acquir Immune Defic Syndr. 2013;64(1):74–8. doi: 10.1097/QAI.0b013e31829f05ac 23774877

17. Gill MM, Hoffman HJ, Bobrow EA, Mugwaneza P, Ndatimana D, Ndayisaba GF, et al. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrolment Results from the Kabeho Study. PLoS ONE. 2016;11:12: e0168671. doi: 10.1371/journal.pone.0168671 28006001

18. Matthews LT, Ribaudo HB, Kaida A, Bennett K, Musinguzi N, Siedner MJ, et al. HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods. J Acquir Immune Defic Syndr. 2016; 71(4):399–406. doi: 10.1097/QAI.0000000000000874 26495883

19. UNAIDS. Get on the Fast Track: The Life Cycle Approach to HIV. Geneva: UNAIDS, 2016.

20. Townsend CL, Byrne L, Cortina-Borja M, Thorne C, de Ruiter A, Lyall H, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2010. AIDS. 2014; 28(7):1049–1057. doi: 10.1097/QAD.0000000000000212 24566097

21. Essajee S, Vojnov L, Penazzato M, Jani I, Siberry GK, Fiscus SA, et al. Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches. J Int AIDS Soc. 2015; 18(Suppl 6):20299. doi: 10.7448/IAS.18.7.20299 26639120